COMMUNIQUÉS West-GlobeNewswire

Accumulus Synergy lance sa plateforme basée sur le cloud très attendue
08/02/2024
Les autorités de réglementation dans le monde entier s’impliquent alors que l’organisation à but non lucratif soutient un projet international axé sur la confiance réglementaire BURLINGAME, Californie, 08 févr. 2024 ( [...]
Cell BioEngines to Present at the 2024 BIO CEO & Investor Conference
08/02/2024
Clinical-Stage Biotech to Unveil Off-the-Shelf Non-Gene Modified Hematopoietic Stem Cells and Its Derived Immune Cell Therapies NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc., a biotechnology company [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
08/02/2024
Bagsværd, Denmark, 8 February 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
Healthcare Triangle Empowers Healthcare Security Management with AI TRiSM Framework Integration, Enhances AI Offerings with CloudEz and DataEz Platforms
08/02/2024
Digital transformation leader advances AI technology and healthcare security PLEASANTON, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company [...]
BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
08/02/2024
ANAHEIM, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, [...]
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
08/02/2024
FREMONT, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, [...]
Accumulus Synergy Launches Highly Anticipated Cloud-Based Platform
08/02/2024
Regulatory Authorities Around the World Engage as the Nonprofit Supports a Global Reliance Project BURLINGAME, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (“Accumulus”) is proud to announce that it [...]
H1 Honored With Spot On the New York Digital Health 100 For Third Straight Year
08/02/2024
Exclusive list recognizes most exciting and innovative health startups in the New York region NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- H1 , the leading source of truth for global healthcare professionals, clinical [...]
Nass Valley Gateway Ltd (NVG.CN) Announces Pending Capital Raise Update for Its Subsidiary Nass Valley Gardens Inc.
08/02/2024
WEST PALM BEACH, FL, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nass Valley Gateway Ltd (CSE: NVG.CN), (OTC Pink: NSVGF), (FSE: 3NVN) is pleased to announce significant corporate developments pertaining to its [...]
AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions
08/02/2024
Efficacy results offer preliminary evidence that Ampligen may reduce fatigue in subjects with Post-COVID conditions Safety results show Ampligen is generally well tolerated in the treatment of Post-COVID Conditions [...]
Trace Genomics CEO & Co-Founder Poornima Parameswaran Elected to the International Myeloma Foundation’s Board of Directors
08/02/2024
LOS ANGELES, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation has recently announced the appointment of Dr. Poornima Parameswaran, the Chief Executive Officer, and Co-founder of Trace Genomics, to [...]
Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients
08/02/2024
Biodexa Pharmaceuticals PLC Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients CARDIFF, United Kingdom, February 8, 2024 (GLOBE NEWSWIRE) -- Biodexa Pharmaceuticals PLC (“ [...]
Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device
08/02/2024
Company’s International Reach Expanding with Latest Regulatory Approval HOUSTON, TEXAS, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that [...]
Trinity Biotech to Present at Emerging Growth Conference
08/02/2024
DUBLIN, Ireland, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces that management will present virtually at the Emerging Growth Conference on March 7, 2024. The [...]
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
08/02/2024
CHAPEL HILL, N.C., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address [...]
Solera Announces Leadership Transition
08/02/2024
CEO Mary Langowski to Assume Role of Chairman of the Board PHOENIX, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Solera Health , the premier technology platform for connecting people seamlessly and easily to health solutions that [...]
Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders
08/02/2024
Bruce Sands, MD, MS., Dr. Burrill B. Crohn Professor of Medicine, Icahn School of Medicine at Mount Sinai and System Chief, Division of Gastroenterology, Mount Sinai Health System Florian Rieder, MD, Associate Staff in [...]
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
08/02/2024
Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP diluted EPS of $0.39 for the fourth quarter of 2023. Reports [...]
Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
08/02/2024
NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) [...]

Pages